Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population.

Savino Bruno,Vito Di Marco,Massimo Iavarone,Luigi Roffi,Andrea Crosignani,Vincenza Calvaruso,Alessio Aghemo,Giuseppe Cabibbo,Mauro Viganò,Vincenzo Boccaccio,Antonio Craxí,Massimo Colombo,Patrick Maisonneuve

Journal of Hepatology（2016）

引用 102|浏览29

暂无评分

摘要

Patients with compensated HCV cirrhosis achieving SVR by IFN obtain a main benefit levelling their survival curve to that of the general population. Wider applicability of IFN-free regimens will possibly make this achievement more generalizable.

查看译文

关键词

SVR,HCV-related cirrhosis,IFN-based therapy,DAA’s,Antiviral therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要